Loading...

Major Indexes

Discounted Cash Flow (DCF) Analysis Unlevered


BioHiTech Global, Inc.

BioHiTech Global, Inc. (BHTG)

$1.99
0.07 (+3.65%)

Operating Data

Year
A/P
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Revenue 1.512.242.423.364.225.497.149.2912.09
Revenue (%)
EBITDA -4.19-5.47-6.16-4.67-5.81-11.54-15.02-19.54-25.42
EBITDA (%)
EBIT -4.55-5.92-6.56-5.14-7.54-12.81-16.67-21.69-28.22
EBIT (%)
Depreciation 0.360.460.400.471.731.271.652.152.80
Depreciation (%)

Balance Sheet Data

Year
A/P
2015
Projected
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Total Cash 0.040.330.902.411.851.872.433.164.11
Total Cash (%)
Account Receivables 0.210.140.270.402.161.041.351.752.28
Account Receivables (%)
Inventories 0.270.710.330.500.470.981.271.662.16
Inventories (%)
Accounts Payable 1.221.201.291.314.693.704.826.278.16
Accounts Payable (%)
Capital Expenditure ----5.116.658.6511.2614.65
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 1.99
Diluted Shares Outstanding 15.67
Cost of Debt
Tax Rate 0.00
After-tax Cost of Debt 0.05
Risk-Free Rate
Market Risk Premium
Cost of Equity 19.98
Total Debt 0.92
Total Equity 31.18
Total Capital 32.10
Debt Weighting 2.85
Equity Weighting 97.15
Wacc

Build Up Free Cash

Year
A/P
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Revenue 1.512.242.423.364.225.497.149.2912.09
EBITDA -4.19-5.47-6.16-4.67-5.81-11.54-15.02-19.54-25.42
EBIT -4.55-5.92-6.56-5.14-7.54-12.81-16.67-21.69-28.22
Tax Rate 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIAT -4.55-5.92-6.56-5.14-7.54-12.81-16.67-21.69-28.22
Depreciation 0.360.460.400.471.731.271.652.152.80
Accounts Receivable -0.07-0.13-0.13-1.751.12-0.31-0.41-0.53
Inventories --0.430.37-0.170.03-0.51-0.30-0.38-0.50
Accounts Payable --0.020.090.023.38-0.981.121.451.89
Capital Expenditure ------1.54-2.00-2.61-3.39
UFCF -4.19-5.86-5.83-4.94-4.15-13.46-16.51-21.48-27.95
WACC
PV UFCF -13.46-13.81-15.03-16.35
SUM PV UFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 19.56
Free cash flow (t + 1) -29.07
Terminal Value -186.82
Present Value of Terminal Value -76.47

Intrinsic Value

Enterprise Value -
Net Debt -0.93
Equity Value -
Shares Outstanding 15.67
Equity Value Per Share -